Product Information
SE-NATAL 19 TABLET is a generic product labeled by Seton Pharmaceuticals, priced at $0.4737 per EA under NDC 13925011601. Its NADAC has been published 426 times since Nov 28, 2013.
SE-NATAL 19 TABLET
.beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodiumStrength
30; 1000; 100; 200; 7; 400; 12; 25; 29; 1; 15; 20; 3; 3; 20 mg/1; [iU]/1; mg/1; mg/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
Manufacturer
Seton PharmaceuticalsNDC
13925011601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
6/17/2026
Approval Type
Unapproved
On Market Since
7/1/2009
Pharmacological Classes
Price Statistics
The NADAC for SE-NATAL 19 TABLET has been published 426 times since Nov 28, 2013, and over the history we have for it it has risen 99.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4737 per EA |
|---|---|
| All-time high | $0.5452 (Sep 10, 2014) |
| All-time low | $0.2381 (Nov 28, 2013) |
| 52-week high | $0.4843 |
| 52-week low | $0.4683 |
| Median price | $0.4223 |
| Average price | $0.4432 |
| Largest weekly change | +51.0% (Apr 23, 2014) |
| Weeks tracked | 426 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-0.6%
1Y
-1.9%
3Y
+32.3%
5Y
+13.4%
All
+99.0%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Seton Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
.beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium pantothenate, calcium carbonate, ferrous fumarate, zinc oxide and docusate sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Blood Coagulation Factor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SE-NATAL 19 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SE-NATAL 19 TABLET, manufactured by Seton Pharmaceuticals, is $0.4737 per EA (NDC 13925011601), effective Jul 1, 2026.
How has the price of SE-NATAL 19 TABLET changed over time?
Over the history we have for it, the NADAC for SE-NATAL 19 TABLET has risen 99.0%. It has been tracked across 426 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SE-NATAL 19 TABLET?
Since Nov 28, 2013, the NADAC for SE-NATAL 19 TABLET has ranged from a low of $0.2381 (Nov 28, 2013) to a high of $0.5452 (Sep 10, 2014), with a median of $0.4223 per EA.
Are there cheaper alternatives to SE-NATAL 19 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SE-NATAL 19 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SE-NATAL 19 TABLET?
SE-NATAL 19 TABLET (NDC 13925011601) is labeled by Seton Pharmaceuticals, and CMS classifies it as a generic product.